West Pharmaceutical Services, Inc. vs Eli Lilly & Co.
WST vs LLY — side-by-side comparison from reported financials. WST leads 2, LLY leads 9 of 11 comparable metrics.
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | WST | LLY |
|---|---|---|
| Price | $366.00 | $1 177.20 |
| Market cap | $25.8B | $1.05T |
| Revenue (TTM) | $3.33B | $79.7B |
| Revenue growth | +2.1% | +31.7% |
| Net margin | 17.0% | 33.5% |
| Free cash flow | $437M | $18.2B |
| Net cash (debt) | $589M | ($35.2B) |
| 1-year price return | +38.9% | +37.6% |
| P/E | 47.7 | 41.6 |
| P/E vs own history (cheap-side %) | 39% | 88% |
| Dividend yield | 0.23% | 0.52% |
| Return on equity | 19% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 10,800 | 50,000 |
Full résumé-style profiles: WST CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.